Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation

• Egile Nagusiak: Yun Hyi Ku (Egilea), Bong-Jun Cho (Egilea), Min Joo Kim (Egilea), Soo Lim (Egilea), Young Joo Park (Egilea), Hak C. Jang (Egilea), Sung Hee Choi (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2017-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Thiazolidinediones (TZDs), peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, exhibit anti-inflammatory and antioxidant properties and inhibit endothelial inflammation and dysfunction, which is anti-atherogenic. However, fluid retention, which may lead to congestive...